Solasia Pharma K.K. (TYO:4597)
30.00
-1.00 (-3.33%)
Jan 21, 2026, 3:30 PM JST
Solasia Pharma K.K. Revenue
Solasia Pharma K.K. had revenue of 42.00M JPY in the quarter ending September 30, 2025, with 366.67% growth. This brings the company's revenue in the last twelve months to 326.00M, up 239.58% year-over-year. In the year 2024, Solasia Pharma K.K. had annual revenue of 316.00M, down -48.78%.
Revenue (ttm)
326.00M
Revenue Growth
+239.58%
P/S Ratio
24.23
Revenue / Employee
14.17M
Employees
23
Market Cap
7.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 316.00M | -301.00M | -48.78% |
| Dec 31, 2023 | 617.00M | -475.00M | -43.50% |
| Dec 31, 2022 | 1.09B | 533.00M | 95.35% |
| Dec 31, 2021 | 559.00M | 105.00M | 23.13% |
| Dec 31, 2020 | 454.00M | -856.00M | -65.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |